At Evotec collaboration and innovation is paramount when developing new and novel anti-infective therapies.
Watch EVP of Anti-infectives Lloyd Payne speak with Forge Therapeutics CEO Zak Zimmerman about recent developments & partnerships in anti-infective drug discovery and development
In this webcast Lloyd Payne, Executive Vice President Head of Anti-Infectives at Evotec speaks with Zak Zimmerman, CEO of Forge Therapeutics about recent developments in anti-infective drug discovery and development and how collaboration and innovation is paramount when developing new and novel therapies.
Lloyd and Zak talk openly about the "platinum age" of antibiotic discovery, some of the challenges and opportunities and how value and new therapies can be derived not only through scientific innovation but also by employing creative business models and collaborations.
Watch the webcast here